Liberty Media Reaches New 52-Week High (LMCA)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model

NEW YORK ( TheStreet) -- Liberty Media Corporation (Nasdaq: LMCA) hit a new 52-week high Tuesday as it is currently trading at $104.38, above its previous 52-week high of $104.34 with 202,537 shares traded as of 11:53 a.m. ET. Average volume has been 698,400 shares over the past 30 days.

Liberty Media has a market cap of $11.03 billion and is part of the services sector and media industry. Shares are unchanged year to date as of the close of trading on Monday.

Liberty Media Corporation, through its subsidiaries, engages in media, communications, and entertainment businesses primarily in North America. The company has a P/E ratio of 8.1, below the average media industry P/E ratio of 23.1 and below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates Liberty Media as a buy. The company's strengths can be seen in multiple areas, such as its solid stock price performance, increase in net income, largely solid financial position with reasonable debt levels by most measures, expanding profit margins and good cash flow from operations. We feel these strengths outweigh the fact that the company has had somewhat disappointing return on equity. You can view the full Liberty Media Ratings Report.

See all 52-week high stocks or get investment ideas from our investment research center.

null

More from Markets

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Global Stocks Rally as US-China Trade War Thaws; Dow Could Test 25,000

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: There Are Some Big Changes Coming to the PGA Championships in 2019

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

Video: One-on-One With Pluralsight's CEO Following Its Successful IPO

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

CBS-Viacom Battle Comes to a Head; FDA Approves Novartis Migraine Drug --ICMYI

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)

Listen: Here's What You Need To Know About ETFs Today (Hint: They're on Fire!)